title: Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies.
authors: Viral Hepatitis Clinical Research Program, The Kirby Institute, UNSW Australia, Sydney, NSW, Australia. mmartinello@kirby.unsw.edu.au.
authors: Marianne
authors: M
authors: Martinello
authors: Margaret
authors: M
authors: Hellard
authors: David
authors: D
authors: Shaw
authors: Kathy
authors: K
authors: Petoumenos
authors: Tanya
authors: T
authors: Applegate
authors: Jason
authors: J
authors: Grebely
authors: Barbara
authors: B
authors: Yeung
authors: Laurence
authors: L
authors: Maire
authors: David
authors: D
authors: Iser
authors: Andrew
authors: A
authors: Lloyd
authors: Alexander
authors: A
authors: Thompson
authors: Joe
authors: J
authors: Sasadeusz
authors: Paul
authors: P
authors: Haber
authors: Gregory J
authors: GJ
authors: Dore
authors: Gail V
authors: GV
authors: Matthews
mesh_terms: D002986:Clinical Trials as Topic; D016174:Hepacivirus; D006526:Hepatitis C / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans